BRD4 and Hepatic fibrosis: It was reported that bromodomain-containing protein 4 (BRD4) was critical in activation of HSCs, while experiments in murine models showed inhibitor of BRD4 could attenuate liver fibrosis and tumorigenesis through repressing TGF-β signaling pathway [31, 32].